[go: up one dir, main page]

WO2008015341A2 - Use of a plant extract as active agent for increasing melanin synthesis in melanocytes - Google Patents

Use of a plant extract as active agent for increasing melanin synthesis in melanocytes Download PDF

Info

Publication number
WO2008015341A2
WO2008015341A2 PCT/FR2007/001333 FR2007001333W WO2008015341A2 WO 2008015341 A2 WO2008015341 A2 WO 2008015341A2 FR 2007001333 W FR2007001333 W FR 2007001333W WO 2008015341 A2 WO2008015341 A2 WO 2008015341A2
Authority
WO
WIPO (PCT)
Prior art keywords
extract
skin
use according
composition
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/001333
Other languages
French (fr)
Other versions
WO2008015341A3 (en
Inventor
Claude Dal Farra
Nouha Domloge
Dominique Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Societe dExtraction des Principes Actifs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0607099A external-priority patent/FR2904542B1/en
Priority claimed from FR0607105A external-priority patent/FR2904546A1/en
Priority claimed from FR0607103A external-priority patent/FR2904545B1/en
Priority claimed from FR0607092A external-priority patent/FR2904556B1/en
Priority claimed from FR0607102A external-priority patent/FR2904544A1/en
Application filed by Societe dExtraction des Principes Actifs SA filed Critical Societe dExtraction des Principes Actifs SA
Publication of WO2008015341A2 publication Critical patent/WO2008015341A2/en
Publication of WO2008015341A3 publication Critical patent/WO2008015341A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • A61K36/5777Theobroma, e.g. cocao or cocoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to the use of a plant extract in a cosmetic composition; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidemic or hair bulb, with a view to giving it a tanned appearance, or to prepare the skin for exposure to the sun.
  • the present invention also relates to the use of a plant extract for the preparation of a pharmaceutical composition; the extract or the composition being intended to promote the increase of the synthesis of melanin in the melanocytes of the epidermis or of the hair bulb for therapeutic purposes, for repigmenting depigmented skin, for example in the case of vitiligo, or for pigmenting the hairs or hair, especially in the treatment and prevention of canities.
  • the plant extract is mainly composed of protein and peptide compounds and is obtained from plants selected from the genera Amaranthus or Oryza or the species Pisum sativum L. (pea), Phaseolus vulgaris (bean) and Theobroma cacao L. ( cocoa).
  • the color of human hair and skin is a function of various factors including seasons of the year, race, sex and age. It is mainly determined by the concentration of melanin produced by melanocytes. Melanocytes are specialized cells that, via particular organelles, melanosomes, synthesize melanin. The synthesis of melanin or melanogenesis is a complex process whose precise mechanisms are not yet elucidated and which schematically involves the following steps:
  • the melanocyte is involved in the epidermal melanic unit, which has a melanocyte surrounded by about 40 neighboring keratinocytes, as melanin is synthesized in melanosomes move from the perinuclear region to the end of the dendrites of melanocytes, and by phagocytosis the end of the dendrites is captured by keratinocytes, degraded membranes and redistributed melanosomes in the keratinocytes, where they will protection up to natural desquamation of the cells.
  • melanin as well as its transport, is regulated by various factors such as, for example, UV radiation, hormones or chemicals.
  • UV radiation an increase in exposure to UV radiation causes the synthesis of pigments and browning of the skin.
  • the pigmentation of hair and hair requires the presence of melanocytes in the bulb of the hair follicle.
  • the hair follicle is a tabular invagination of the epidemic that penetrates to the deep layers of the dermis.
  • the melanocytes in the bulb of the hair follicle are in an active state, that is, they synthesize melanin. These pigments are transmitted to the keratinocytes intended to form the hair shaft, which will lead to the growth of a pigmented hair or hair.
  • canitia naturally whitening of hair
  • melanin melanin
  • These new compounds are particularly useful as an alternative to sun exposure, to prepare the skin and protect it from the sun's rays, to obtain a tan more intense after exposure to the sun, to prolong the natural pigmentation of the skin after exposure to the sun. sun or to prevent and / or limit and / or stop the development of canities and even maintain the natural pigmentation of hair and / or gray or white hairs.
  • pigmentation of the skin is meant the coloring of the skin or hair determined by the melanin concentration.
  • exogenous dye a dye, or a chemical substance, is meant to react with the superficial layers of the epidemic to cause the appearance of a pigmentation of the skin completely independent of the presence of melanin.
  • exogenous dyes is dihydroxyacetone, or DHA.
  • DHA dihydroxyacetone
  • vitiligo which is an autoimmune disease characterized by the appearance on the skin of white patches related to a lack of pigmentation or pityriasis versicolor, a superficial mycosis. causing the appearance of light spots that may appear immediately or after exposure to the sun.
  • the main objective of the present invention is to provide a novel active agent that significantly promotes melanin synthesis in the melanocytes of the epidermis and hair bulb.
  • the inventors have indeed demonstrated a biological activity and, more particularly dermatological and cosmetic, plant extracts obtained from plants selected from the genera Amaranthus or Oryza or species Pisum sativum L. (pea), Phaseolus vulgaris (bean) ) and Theobroma cacao L. (cocoa).
  • pro-pigmenting active agent a compound capable of promoting the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb.
  • hair and hair is meant all the hairy appendages and in particular also the eyelashes and the eyebrows.
  • compositions according to the invention may be applied by any appropriate route, in particular oral, parenteral or external topical, and their formulation will be adapted by those skilled in the art, in particular for cosmetic or dermatological compositions.
  • compositions according to the invention are intended for topical administration. They contain a physiologically acceptable medium, in particular a cosmetologically or pharmaceutically acceptable medium, in particular a dermatologically acceptable medium.
  • the subject of the invention is primarily the use in a cosmetic composition of a plant extract, consisting mainly of compounds of protein and peptide nature; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb.
  • extract refers to any isolated substance or preparation obtained from plant material. It is obtained, for example, by dissolving the active components by means of solvents (such as water, alcohol, etc.) then by concentration and purification of these active ingredients, for example by evaporation of the solvents.
  • solvents such as water, alcohol, etc.
  • one of the many plants of the genus is used.
  • the species Amaranthus hypochondriacus (amaranth) can advantageously be used according to the invention.
  • the species Oryza sativa L. (rice) can advantageously be used according to the invention.
  • the plant material used will be the seed or the grain and preferably the seed freed from its envelope by a dehulling step.
  • the plant is ground using a plant grinder.
  • the powder thus obtained may subsequently be "delipidated” with the aid of a conventional organic solvent (such as, for example, an alcohol, hexane or acetone).
  • a conventional organic solvent such as, for example, an alcohol, hexane or acetone.
  • the extraction of proteins from the plant is then conventionally carried out (Osborne, 1924); the crushed plant being suspended in an alkaline solution.
  • the soluble fraction is collected after centrifugation and filtration steps, this crude solution then constituting a first form of the extract containing the proteins, carbohydrates and optionally lipids.
  • Proteins are then precipitated by varying the ionic strength and acidifying the medium to remove soluble components and nucleic acids.
  • the precipitate is then washed with a solvent such as, for example, ethanol or methanol and the solvent is evaporated by drying in vacuo.
  • the protein-rich precipitate is redissolved in water or other solvent and then constitutes a more purified form of the extract.
  • the extraction can also be carried out in neutral or acidic medium.
  • the precipitation step is then carried out using a conventional precipitation agent such as salts (sodium chloride, ammonium sulfate).
  • the precipitate obtained can be separated from the precipitating agents by dialysis after redissolving in water or another solvent. At this stage, the extract obtained contains at least 70% of compounds of protein and peptide nature.
  • the isolated protein fraction according to the invention is then hydrolyzed under mild conditions to generate polypeptides and soluble peptides.
  • Hydrolysis is defined as a chemical reaction involving the cleavage of a molecule by water, this reaction being possible in a neutral, acidic or basic medium.
  • the hydrolysis is carried out chemically and / or advantageously by proteolytic enzymes.
  • endoproteases and exopeptidases of plant origin papain, bromelain, ficine
  • microorganisms Aspergillus, Rhizopus, Bacillus, etc.
  • the active extract may be further purified by fractionation, in particular by a method of the chromatographic type or purified and concentrated by a dialysis method. Any of the more or less purified forms of the extract are then solubilized in water or in any mixture containing water, then sterilized by ultrafiltration.
  • the plant extract obtained according to the invention is analyzed qualitatively and quantitatively for its content of compounds of protein and peptide nature.
  • Protein and peptide compounds are understood to mean protein fragments, peptides and free amino acids present in the mixture.
  • the peptides, amino acids and protein fragments are determined according to conventional techniques, which are well known to those skilled in the art.
  • the active plant extract contains a quantity of protein and peptide compounds representing between 30 and 90% of the total weight of the dry matter, more particularly this amount is between 60 and 90% of the total weight of the dry matter. and 80% of the total weight of the dry matter.
  • the invention has the second object the use of an extract according to the invention for the preparation of a pharmaceutical composition; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb in order to repigment skin depigmented for example in the case of vitiligo, or in order to pigment hair or hair , especially in the treatment and prevention of canities.
  • the invention also relates to the use of a plant extract according to the invention for the preparation of a pharmaceutical composition; the extract or the composition being intended to attenuate the pigmentary disorders associated with skin hypopigmentation, in particular vitiligo.
  • the invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, of a plant extract according to the invention; the extract or the composition being intended to promote the pigmentation of the hairs and / or the hair.
  • the invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, of a plant extract according to the invention; the extract or the composition being intended to prepare the skin for exposure to the sun.
  • the invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, a plant extract according to the invention; the extract or the composition being intended, by increasing melanin synthesis, to protect the skin from sunlight.
  • the use of the plant extract or of the composition containing it is intended to protect the skin from environmental stress.
  • the plant extract is first solubilized in one or more cosmetically or pharmaceutically acceptable solvents such as water, glycerol, propylene glycol, butylene glycol, ethoxylated or propoxylated diglycols, ethanol, propanol or isopropanol.
  • one or more cosmetically or pharmaceutically acceptable solvents such as water, glycerol, propylene glycol, butylene glycol, ethoxylated or propoxylated diglycols, ethanol, propanol or isopropanol.
  • the plant extract is first solubilized in a cosmetic or pharmaceutical vector such as liposomes or adsorbed on organic powdery polymers, mineral supports such as talcs and bentonites, and more generally solubilized in, or attached to, any cosmetically or pharmaceutically acceptable carrier.
  • a cosmetic or pharmaceutical vector such as liposomes or adsorbed on organic powdery polymers, mineral supports such as talcs and bentonites, and more generally solubilized in, or attached to, any cosmetically or pharmaceutically acceptable carrier.
  • the plant extract is used in an amount representing from 0.0001% to 20% of the total weight of the composition, and preferably in a quantity representing from 0.05% to 5% of the total weight of the composition.
  • the content of protein and peptide compounds in the compositions of the present invention will then be from 0.00003% to 18% and preferably from 0.015% to 9% of the total weight of the composition, for plant extracts containing between 30 and 90% of compounds of protein and peptide nature. Or, the content of protein and peptide compounds in the compositions of the present invention will be 0.0006% to
  • a pro-pigmenting compound according to the invention offers outlets in the self-tanning products and the products promoting tanning.
  • the invention relates to the use of plant extract for the manufacture of products for artificial tanning and / or browning of the skin.
  • the invention also relates to the use of plant extract to improve the intensity and / or the homogeneity and / or the persistence of the coloration produced on the skin and / or the hair.
  • compositions according to the present invention will be in a form suitable for topical administration to the skin, and cover all cosmetic or dermatological forms.
  • These compositions must therefore contain a cosmetically and / or dermatologically acceptable medium, that is to say compatible with the skin, hair or hair.
  • These compositions may especially be in the form of creams, O / W emulsions, W / O emulsions or multiple emulsions, solutions, suspensions, gels, milks, lotions, sticks or even powders, suitable for application to the skin, the lips and / or the hair.
  • These compositions comprise the excipients necessary for their formulation, such as solvents, thickeners, diluents, surfactants, antioxidants, dyes, preservatives, perfumes.
  • composition that may be used according to the invention may in particular consist of a composition for hair care, and in particular a shampoo, a conditioner, a setting lotion, a treatment lotion, a cream or a styling gel, a restructuring lotion for hair, a mask, etc.
  • the cosmetic composition according to the invention can be used in particular in treatments using an application that is followed or not followed by rinsing, or in the form of shampoo.
  • It can also be in the form of dye or mascara to be applied with a brush or a comb, in particular on eyelashes, eyebrows or hair.
  • plant extracts according to the invention may be used as the only pro-pigmenting agent or in combination with at least one other active agent, in a cosmetic composition or for the preparation of a dermatological and / or pharmaceutical composition.
  • compositions that can be used according to the invention also contain at least one other agent that promotes the pigmentation of the skin, hair and / or hair.
  • Such compounds are in particular tyrosinase substrates, such as tyrosine or L-DOPA, prostaglandins, or activating compounds of the cAMP pathway such as pro-opiomelanocortin derivatives, adenosine, or forkoline or its derivatives. It may also be mentioned plant extracts such as bitter orange (citrus aurantiur) or chrysanthemum (Chrysanthemum morifolium), described in particular in patents FR 2845285 and EP1014934.
  • tyrosinase substrates such as tyrosine or L-DOPA
  • prostaglandins or activating compounds of the cAMP pathway
  • activating compounds of the cAMP pathway such as pro-opiomelanocortin derivatives, adenosine, or forkoline or its derivatives.
  • plant extracts such as bitter orange (citrus aurantiur) or chrysanthemum (Chrysanthemum morifolium),
  • Such compounds are also found in the family of exogenous dyes of the superficial layers of the epidemic, such as dihydroxyacetone (DHA), erythrulose, extracts of henna leaves, described in particular in patents EP 0742002 and FR2779958.
  • DHA dihydroxyacetone
  • erythrulose extracts of henna leaves
  • the active agent can be obtained from an extract of grains of the species Pisum sativum L. (pea), but of course the extract can be prepared from plants of minus any of the many varieties and species belonging to the genus Pisum.
  • the active agent can be obtained from a grain extract of the species Vhaseolus vulgaris (bean).
  • the extract can be prepared from plants of at least one of many varieties and species belonging to the genus Phaseolus.
  • the active agent can be obtained from an extract of beans (or grains) of the species Theobroma cacao L. (cocoa).
  • the extract may be prepared from plants of at least one of many varieties and species belonging to the genus Theobroma.
  • the active agent can be obtained from a seed extract of the species Amaranthus hypochondriacus (amaranth).
  • the extract can be prepared from plants of at least one of many varieties and species belonging to the genus Amaranthus.
  • the active agent can be obtained from an extract of grains of the species Oryza sativa L. (rice).
  • the extract can be prepared from plants of at least one of the many varieties and species belonging to the genus Oryza.
  • a first step 1 kg of shelled grains are delipidated by the action of an organic solvent: hexane.
  • the grains are then milled in a knife mill and then suspended in an aqueous alkaline solution (1/10 dilution). This mixture is stirred for a time long enough to allow the solubilization of the soluble fractions.
  • the extraction temperature is variable (between 4 and 80 ° C); preferably the operation will be performed cold.
  • the medium is clarified by centrifugation and then filtered through a plate filter.
  • This filtrate which contains the soluble fractions of the plant is then subjected to precipitation of the proteins by varying the ionic strength in neutral or acidic medium, which allows to eliminate soluble carbohydrate components, lipids and nucleic acids.
  • the supernatant is removed and the precipitate is then washed with a solvent such as, for example, ethanol or methanol and the solvent is evaporated by drying in vacuo.
  • a solvent such as, for example, ethanol or methanol
  • the protein-rich precipitate is dissolved in water or another solvent.
  • the extraction can also be carried out in neutral or acidic medium.
  • the crude protein extract is then subjected to a series of gentle and selective hydrolyses consisting of chemical and enzymatic hydrolyses.
  • hydrolysis in the presence of exopeptidases (papain, ficin).
  • the hydrolyzate is then purified and membrane-dialyzed to remove the high molecular weight compounds.
  • a light-colored hydrolyzate titrant of 15 to 30 g / l of dry extract and containing a quantity of protein and peptide compounds representing approximately 70% of the total weight of the dry matter is then obtained.
  • the hydrolyzed extract according to the invention is then diluted so that the protein concentration determined by the Lowry method is between 0.5 and 2 g / l.
  • compositions were obtained by simple mixing of the various components. The quantities indicated are given as a percentage of weight.
  • Aqueous phase Aqueous phase :
  • Aqueous phase B Dihydroxyacetone 2.00%

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the use of a plant extract in a cosmetic composition or for the preparation of a pharmaceutical composition, as active agent intended to promote increased melanin synthesis in the melanocytes of the epidermis or of the hair bulb. The plant extract is mainly constituted of compounds of protein and peptide nature and is obtained from plants selected from the genus Amaranthus or Oryza or the species Pisum sativum L. (pea), Phaseolus vulgaris (bean) and Theobroma cacao L. (cocoa).

Description

UTILISATION D'UN EXTRAIT VEGETAL EN TANT QU'AGENT ACTIF POUR AUGMENTER LA SYNTHESE DE MELANINE DANS LES MELANOCYTES USE OF PLANT EXTRACT AS ACTIVE AGENT TO INCREASE MELANIN SYNTHESIS IN MELANOCYTES

La présente invention concerne l'utilisation d'un extrait végétal dans une composition cosmétique ; l'extrait ou la composition étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épidémie ou du bulbe pileux, en vue de lui donner un aspect bronzé, ou de préparer la peau à une exposition au soleil. La présente invention concerne également l'utilisation d'un extrait végétal pour la préparation d'une composition pharmaceutique ; l'extrait ou la composition étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de Pépiderme ou du bulbe pileux à des fins thérapeutiques, pour repigmenter la peau dépigmentée par exemple dans le cas du vitiligo, ou pour pigmenter les poils ou les cheveux, en particulier dans le traitement et la prévention de la canitie. L'extrait végétal est principalement constitué de composés de nature protéique et peptidique et est obtenu à partir de plantes choisies parmi les genres Amaranthus ou Oryza ou les espèces Pisum sativum L. (pois), Phaseolus vulgaris (haricot) et Theobroma cacao L. (cacao).The present invention relates to the use of a plant extract in a cosmetic composition; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidemic or hair bulb, with a view to giving it a tanned appearance, or to prepare the skin for exposure to the sun. The present invention also relates to the use of a plant extract for the preparation of a pharmaceutical composition; the extract or the composition being intended to promote the increase of the synthesis of melanin in the melanocytes of the epidermis or of the hair bulb for therapeutic purposes, for repigmenting depigmented skin, for example in the case of vitiligo, or for pigmenting the hairs or hair, especially in the treatment and prevention of canities. The plant extract is mainly composed of protein and peptide compounds and is obtained from plants selected from the genera Amaranthus or Oryza or the species Pisum sativum L. (pea), Phaseolus vulgaris (bean) and Theobroma cacao L. ( cocoa).

La couleur des cheveux et de la peau humaine est fonction de différents facteurs et notamment des saisons de l'année, de la race, du sexe et de l'âge. Elle est principalement déterminée par la concentration de mélanine produite par les mélanocytes. Les mélanocytes sont les cellules spécialisées qui, par l'intermédiaire d'organites particuliers, les mélanosomes, synthétisent la mélanine. La synthèse de la mélanine ou mélanogénèse est un processus complexe dont les mécanismes précis ne sont pas encore élucidés et qui fait intervenir schématiquement les étapes suivantes :The color of human hair and skin is a function of various factors including seasons of the year, race, sex and age. It is mainly determined by the concentration of melanin produced by melanocytes. Melanocytes are specialized cells that, via particular organelles, melanosomes, synthesize melanin. The synthesis of melanin or melanogenesis is a complex process whose precise mechanisms are not yet elucidated and which schematically involves the following steps:

Tyrosine *" Dopa * Dopaquinone *" Dopachrome *" Mélanine Dans l'épiderme, le mélanocyte est impliqué dans l'unité mélanique épidermique qui comporte un mélanocyte entouré d'environ 40 kératinocytes voisins. Au fur et à mesure que la mélanine est synthétisée dans les mélanosomes, ceux-ci se déplacent de la région périnucléaire vers l'extrémité des dendrites des mélanocytes. Par phagocytose, l'extrémité des dendrites est capturée par les kératinocytes, les membranes dégradées et les mélanosomes redistribués dans les kératinocytes, où ils assureront une protection jusqu'à la desquamation naturelle des cellules. La production de mélanine, ainsi que son transport, sont régulés par différents facteurs tels que, par exemple, le rayonnement UV, les hormones ou les produits chimiques. Ainsi, une augmentation de l'exposition aux rayonnements UV provoque la synthèse de pigments et le brunissement de la peau. La pigmentation du cheveu et des poils requiert la présence de mélanocytes au niveau du bulbe du follicule pileux. Le follicule pileux est une invagination tabulaire de l'épidémie qui s'enfonce jusqu'aux couches profondes du derme. Les mélanocytes au niveau du bulbe du follicule pileux sont dans un état actif, c'est-à-dire qu'ils synthétisent de la mélanine. Ces pigments sont transmis aux kératinocytes destinés à former la tige pilaire, ce qui conduira à la pousse d'un cheveu ou d'un poil pigmenté.Tyrosine * "Dopa * Dopaquinone * " Dopachrome * "Melanin In the epidermis, the melanocyte is involved in the epidermal melanic unit, which has a melanocyte surrounded by about 40 neighboring keratinocytes, as melanin is synthesized in melanosomes move from the perinuclear region to the end of the dendrites of melanocytes, and by phagocytosis the end of the dendrites is captured by keratinocytes, degraded membranes and redistributed melanosomes in the keratinocytes, where they will protection up to natural desquamation of the cells. The production of melanin, as well as its transport, is regulated by various factors such as, for example, UV radiation, hormones or chemicals. Thus, an increase in exposure to UV radiation causes the synthesis of pigments and browning of the skin. The pigmentation of hair and hair requires the presence of melanocytes in the bulb of the hair follicle. The hair follicle is a tabular invagination of the epidemic that penetrates to the deep layers of the dermis. The melanocytes in the bulb of the hair follicle are in an active state, that is, they synthesize melanin. These pigments are transmitted to the keratinocytes intended to form the hair shaft, which will lead to the growth of a pigmented hair or hair.

Il est admis que la canitie (blanchiment naturel des cheveux) est associée à une diminution de mélanine dans la tige pilaire.It is accepted that canitia (natural whitening of hair) is associated with a decrease of melanin in the hair shaft.

De nos jours, il est important d'avoir bonne mine et une peau bronzée est toujours signe de bonne santé. Cependant, le bronzage naturel n'est pas toujours sans risque dans la mesure où il nécessite des expositions prolongées aux rayonnements UV, qui sont susceptibles en contrepartie d'induire une altération des cellules cutanées, notamment dans le cas des individus de phototypes clairs. La peau vieillit prématurément, devient sèche et se caractérise par de nombreuses rides et taches de vieillesse. Il est donc souhaitable de trouver une alternative au bronzage naturel qui soit compatible avec les exigences de santé des individus. D'autre part, on sait que dans la plupart des populations le maintien d'une coloration constante de la chevelure, signe de jeunesse, est une aspiration forte. La recherche de composés pouvant favoriser la synthèse de la mélanine dans la peau et les cheveux est une préoccupation de la dermatologie et de la cosmétique. Ces nouveaux composés seraient notamment utiles comme alternative aux expositions solaires, pour préparer la peau et protéger celle-ci des rayons du soleil, pour obtenir un bronzage plus intense après une exposition au soleil, pour prolonger la pigmentation naturelle de la peau après une exposition au soleil ou pour prévenir et/ou limiter et/ou stopper le développement de la canitie et même maintenir la pigmentation naturelle des cheveux et/ou des poils gris ou blancs.Nowadays, it is important to look good and tanned skin is always a sign of good health. However, natural tanning is not always without risk insofar as it requires prolonged exposures to UV radiation, which are likely in return to induce an alteration of skin cells, especially in the case of individuals of clear phototypes. The skin ages prematurely, becomes dry and is characterized by many wrinkles and age spots. It is therefore desirable to find an alternative to natural tanning that is compatible with the health requirements of individuals. On the other hand, we know that in most populations the maintenance of a constant coloring of the hair, sign of youth, is a strong aspiration. The search for compounds that can promote the synthesis of melanin in the skin and hair is a concern of dermatology and cosmetics. These new compounds are particularly useful as an alternative to sun exposure, to prepare the skin and protect it from the sun's rays, to obtain a tan more intense after exposure to the sun, to prolong the natural pigmentation of the skin after exposure to the sun. sun or to prevent and / or limit and / or stop the development of canities and even maintain the natural pigmentation of hair and / or gray or white hairs.

On entend par pigmentation naturelle de la peau, la coloration de la peau ou des cheveux déterminée par la concentration en mélanine.By natural pigmentation of the skin is meant the coloring of the skin or hair determined by the melanin concentration.

A cet égard, il a été proposé de nombreuses solutions par apport de colorants exogènes. On entend par colorant exogène, un colorant, ou une substance chimique, capable de réagir avec les couches superficielles de l'épidémie pour provoquer l'apparition d'une pigmentation de la peau tout à fait indépendante de la présence de mélanine. L'un des colorants exogènes le plus connu est la dihydroxyacétone, ou DHA. Toutefois, seule la stimulation de la pigmentation de la peau et/ou des cheveux par la voie naturelle permet une réelle protection vis à vis des rayonnements UV et reste la voie idéale de stimulation de la pigmentation. Ainsi il a été proposé dans l'art antérieur la préparation et l'utilisation d'activateurs de la biosynthèse de la mélanine (FR828097, FR 2831438, FR 2845285) faisant intervenir des hormones (alpha MSH ou ses dérivés WO2006037188) ou des prostaglandines (WO9511003).In this respect, many solutions have been proposed by adding exogenous dyes. By exogenous dye, a dye, or a chemical substance, is meant to react with the superficial layers of the epidemic to cause the appearance of a pigmentation of the skin completely independent of the presence of melanin. One of the best known exogenous dyes is dihydroxyacetone, or DHA. However, only the stimulation of the pigmentation of the skin and / or the hair by the natural way allows a real protection vis-à-vis the UV radiations and remains the ideal way of stimulation of the pigmentation. Thus, it has been proposed in the prior art the preparation and use of activators of melanin biosynthesis (FR828097, FR 2831438, FR 2845285) involving hormones (alpha MSH or its derivatives WO2006037188) or prostaglandins ( WO9511003).

D'autre part, il existe des pathologies liées à la pigmentation comme le vitiligo qui est une maladie auto-immune se caractérisant par l'apparition sur la peau de plaques blanches liées à un déficit de pigmentation ou encore le pityriasis versicolor, une mycose superficielle provoquant l'apparition de taches claires pouvant se manifester d'emblée ou après une exposition au soleil.On the other hand, there are pathologies related to pigmentation such as vitiligo which is an autoimmune disease characterized by the appearance on the skin of white patches related to a lack of pigmentation or pityriasis versicolor, a superficial mycosis. causing the appearance of light spots that may appear immediately or after exposure to the sun.

La présente invention a pour principal objectif de fournir un nouvel agent actif favorisant de façon importante la synthèse de mélanine dans les mélanocytes de l'épiderme et du bulbe pileux. Les inventeurs ont en effet mis en évidence une activité biologique et, plus particulièrement dermatologique et cosmétique, d'extraits végétaux obtenus à partir de plantes choisies parmi les genres Amaranthus ou Oryza ou les espèces Pisum sativum L. (pois), Phaseolus vulgaris (haricot) et Theobroma cacao L. (cacao).The main objective of the present invention is to provide a novel active agent that significantly promotes melanin synthesis in the melanocytes of the epidermis and hair bulb. The inventors have indeed demonstrated a biological activity and, more particularly dermatological and cosmetic, plant extracts obtained from plants selected from the genera Amaranthus or Oryza or species Pisum sativum L. (pea), Phaseolus vulgaris (bean) ) and Theobroma cacao L. (cocoa).

L'utilisation cosmétique d'extraits végétaux obtenus à partir de ce type de plantes a déjà été décrite dans de nombreux brevets. Ainsi les brevets FR 2 746 303, JP8012549, JP10330242 décrivent l'utilisation d'extraits d'amarante, dans le domaine de la cosmétique. De même, l'utilisation d'extraits de riz, dans le domaine de la cosmétique, a déjà été décrite, entre autre, dans les brevets US5853705 et JP9087133. D'autre part, des compositions cosmétiques pour contrôler la pigmentation de la peau, contenant des polyphénols de cacao ont été décrites (WO 2006/117465). Toutefois, à la connaissance de la demanderesse, l'utilisation d'extraits végétaux, principalement constitués de composés de nature protéique et peptidique, obtenus à partir de plantes choisies parmi les genres Amaranthus ou Oryza ou les espèces Pisum sativum L. (pois), Phaseolus vulgaris (haricot) et Theobroma cacao L. (cacao), pour favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épiderme ou du bulbe pileux, n'a pas encore été exposée.The cosmetic use of plant extracts obtained from this type of plant has already been described in numerous patents. Thus patents FR 2 746 303, JP8012549 and JP10330242 describe the use of extracts of amaranth in the field of cosmetics. Similarly, the use of rice extracts in the field of cosmetics has already been described, inter alia, in patents US5853705 and JP9087133. On the other hand, cosmetic compositions for controlling the pigmentation of the skin, containing cocoa polyphenols have been described (WO 2006/117465). However, to the knowledge of the applicant, the use of plant extracts, mainly consisting of protein and peptide compounds, obtained from plants selected from the genera Amaranthus or Oryza or species Pisum sativum L. (pea), Phaseolus vulgaris (bean) and Theobroma cacao L. (cocoa), to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb, has not yet been exposed.

Par agent actif pro-pigmentant, on entend un composé capable de favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épiderme ou du bulbe pileux.By pro-pigmenting active agent is meant a compound capable of promoting the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb.

Par poils et cheveux on entend l'ensemble des annexes pileuses et notamment également les cils et les sourcils.By hair and hair is meant all the hairy appendages and in particular also the eyelashes and the eyebrows.

Les compositions selon l'invention pourront être appliquées par toute voie appropriée, notamment orale, parentérale ou topique externe, et leur formulation sera adaptée par l'homme du métier, en particulier pour des compositions cosmétiques ou dermatologiques.The compositions according to the invention may be applied by any appropriate route, in particular oral, parenteral or external topical, and their formulation will be adapted by those skilled in the art, in particular for cosmetic or dermatological compositions.

Avantageusement, les compositions selon l'invention sont destinées à une administration par voie topique. Elles contiennent un milieu physiologiquement acceptable, en particulier un milieu cosmétologiquement ou pharmaceutiquement, notamment dermatologiquement acceptable.Advantageously, the compositions according to the invention are intended for topical administration. They contain a physiologically acceptable medium, in particular a cosmetologically or pharmaceutically acceptable medium, in particular a dermatologically acceptable medium.

Ainsi, l'invention a pour objet premier l'utilisation dans une composition cosmétique d'un extrait végétal, principalement constitué de composés de nature protéique et peptidique ; l'extrait ou la composition étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épiderme ou du bulbe pileux.Thus, the subject of the invention is primarily the use in a cosmetic composition of a plant extract, consisting mainly of compounds of protein and peptide nature; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb.

Le terme "extrait" désigne toute substance ou préparation isolée, obtenue à partir de matière végétale. Il s'obtient, par exemple, par dissolution des composants actifs au moyen de solvants (comme l'eau, l'alcool, etc.) puis par concentration et purification de ces actifs, par exemple, par évaporation des solvants.The term "extract" refers to any isolated substance or preparation obtained from plant material. It is obtained, for example, by dissolving the active components by means of solvents (such as water, alcohol, etc.) then by concentration and purification of these active ingredients, for example by evaporation of the solvents.

Plus particulièrement selon l'invention on utilise une des nombreuses plantes des genresMore particularly according to the invention one of the many plants of the genus is used.

Amaranthus ou Oryza ou des espèces Pisum sativum L. (pois), Phaseolus vulgaris (haricot) ou Theobroma cacao L. (cacao).Amaranthus or Oryza or species Pisum sativum L. (pea), Phaseolus vulgaris (bean) or Theobroma cacao L. (cocoa).

Lorsque l'on utilise les plantes du genre Amaranthus on peut utiliser avantageusement selon l'invention l'espèce Amaranthus hypochondriacus (amarante).When using the plants of the genus Amaranthus, the species Amaranthus hypochondriacus (amaranth) can advantageously be used according to the invention.

Lorsque l'on utilise les plantes du genre Oryza, on peut utiliser avantageusement selon l'invention l'espèce Oryza sativa L. (riz).When plants of the genus Oryza are used, the species Oryza sativa L. (rice) can advantageously be used according to the invention.

Selon l'invention le matériel végétal utilisé sera la graine ou le grain et préférentiellement la graine débarrassée de son enveloppe par une étape de décorticage.According to the invention the plant material used will be the seed or the grain and preferably the seed freed from its envelope by a dehulling step.

Toute méthode d'extraction ou de purification connue de l'homme du métier peut être utilisée afin de préparer l'hydrolysat selon l'invention.Any method of extraction or purification known to those skilled in the art can be used to prepare the hydrolyzate according to the invention.

Dans une première étape, la plante est broyée à l'aide d'un broyeur à plantes. La poudre ainsi obtenue peut ultérieurement être "délipidée" à l'aide d'un solvant organique classique (comme par exemple un alcool, un hexane ou de l'acétone).In a first step, the plant is ground using a plant grinder. The powder thus obtained may subsequently be "delipidated" with the aid of a conventional organic solvent (such as, for example, an alcohol, hexane or acetone).

On réalise ensuite classiquement l'extraction des protéines de la plante (Osborne, 1924) ; le broyât de plante étant mis en suspension dans une solution alcaline. La fraction soluble est recueillie après des étapes de centrifugation et de filtration, cette solution brute constituant alors une première forme de l'extrait contenant les protéines, les glucides et éventuellement des lipides. Les protéines sont ensuite précipitées en faisant varier la force ionique et en acidifiant le milieu, ce qui permet d'éliminer les composants solubles et les acides nucléiques. Le précipité est ensuite lavé à l'aide d'un solvant tel que, par exemple, l'éthanol ou le méthanol puis le solvant est évaporé par séchage sous vide. Le précipité riche en protéines est remis en solution dans l'eau ou un autre solvant et constitue alors une forme plus purifiée de l'extrait.The extraction of proteins from the plant is then conventionally carried out (Osborne, 1924); the crushed plant being suspended in an alkaline solution. The soluble fraction is collected after centrifugation and filtration steps, this crude solution then constituting a first form of the extract containing the proteins, carbohydrates and optionally lipids. Proteins are then precipitated by varying the ionic strength and acidifying the medium to remove soluble components and nucleic acids. The precipitate is then washed with a solvent such as, for example, ethanol or methanol and the solvent is evaporated by drying in vacuo. The protein-rich precipitate is redissolved in water or other solvent and then constitutes a more purified form of the extract.

L'extraction peut également être réalisée en milieu neutre ou acide. L'étape de précipitation s'effectue alors à l'aide d'un agent classique de précipitation tel que les sels (chlorure de sodium, sulfate d'ammonium). Le précipité obtenu peut être séparé des agents de précipitation par dialyse après remise en solution dans de l'eau ou un autre solvant. A ce stade, l'extrait obtenu contient au minimum 70 % de composés de nature protéique et peptidique.The extraction can also be carried out in neutral or acidic medium. The precipitation step is then carried out using a conventional precipitation agent such as salts (sodium chloride, ammonium sulfate). The precipitate obtained can be separated from the precipitating agents by dialysis after redissolving in water or another solvent. At this stage, the extract obtained contains at least 70% of compounds of protein and peptide nature.

La fraction protéique isolée selon l'invention est ensuite hydrolysée dans des conditions ménagées pour générer des polypeptides et des peptides solubles. L'hydrolyse se définit comme étant une réaction chimique impliquant le clivage d'une molécule par de l'eau, cette réaction pouvant se faire en milieu neutre, acide ou basique. Selon l'invention, l'hydrolyse est réalisée par voie chimique et/ou de façon avantageuse par des enzymes protéolytiques. On peut alors citer l'utilisation des endoprotéases et exopeptidases d'origine végétale (papaïne, bromelaine, ficine) et de micro-organismes (Aspergillus, Rhizopus, Bacillus, etc.). La solution obtenue constitue l'extrait actif. L'extrait actif peut être encore purifié par fractionnement, notamment par une méthode de type chromatographique ou purifié et concentré par un procédé de dialyse. L'une quelconque des formes plus ou moins purifiées de l'extrait est alors solubilisée dans de l'eau ou dans tout mélange contenant de l'eau, puis stérilisée par ultrafiltration.The isolated protein fraction according to the invention is then hydrolyzed under mild conditions to generate polypeptides and soluble peptides. Hydrolysis is defined as a chemical reaction involving the cleavage of a molecule by water, this reaction being possible in a neutral, acidic or basic medium. According to the invention, the hydrolysis is carried out chemically and / or advantageously by proteolytic enzymes. We can then mention the use of endoproteases and exopeptidases of plant origin (papain, bromelain, ficine) and microorganisms (Aspergillus, Rhizopus, Bacillus, etc.). The solution obtained constitutes the active extract. The active extract may be further purified by fractionation, in particular by a method of the chromatographic type or purified and concentrated by a dialysis method. Any of the more or less purified forms of the extract are then solubilized in water or in any mixture containing water, then sterilized by ultrafiltration.

L'extrait végétal obtenu selon l'invention est analysé qualitativement et quantitativement pour sa teneur en composés de nature protéique et peptidique. On entend par composés de nature protéique et peptidique, les fragments de protéines, les peptides et les acides aminés libres présents dans le mélange. Les peptides, acides aminés et fragments de protéines sont dosés selon les techniques classiques, bien connues de l'homme du métier. Ainsi, selon un mode de réalisation avantageux de l'invention, l'extrait végétal actif contient une quantité de composés de nature protéique et peptidique représentant entre 30 et 90 % du poids total de la matière sèche, plus particulièrement cette quantité est comprise entre 60 et 80 % du poids total de la matière sèche.The plant extract obtained according to the invention is analyzed qualitatively and quantitatively for its content of compounds of protein and peptide nature. Protein and peptide compounds are understood to mean protein fragments, peptides and free amino acids present in the mixture. The peptides, amino acids and protein fragments are determined according to conventional techniques, which are well known to those skilled in the art. Thus, according to an advantageous embodiment of the invention, the active plant extract contains a quantity of protein and peptide compounds representing between 30 and 90% of the total weight of the dry matter, more particularly this amount is between 60 and 90% of the total weight of the dry matter. and 80% of the total weight of the dry matter.

L'invention a pour deuxième objet l'utilisation d'un extrait selon l'invention pour la préparation d'une composition pharmaceutique ; l'extrait ou la composition étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de Fépiderme ou du bulbe pileux afin de repigmenter la peau dépigmentée par exemple dans le cas du vitiligo, ou afin de pigmenter les poils ou les cheveux, en particulier dans le traitement et la prévention de la canitie.The invention has the second object the use of an extract according to the invention for the preparation of a pharmaceutical composition; the extract or the composition being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb in order to repigment skin depigmented for example in the case of vitiligo, or in order to pigment hair or hair , especially in the treatment and prevention of canities.

L'invention se rapporte aussi à l'utilisation d'un extrait végétal selon l'invention pour la préparation d'une composition pharmaceutique ; l'extrait ou la composition étant destinés à atténuer les désordres pigmentaires associés à une hypopigmentation de la peau, notamment le vitiligo.The invention also relates to the use of a plant extract according to the invention for the preparation of a pharmaceutical composition; the extract or the composition being intended to attenuate the pigmentary disorders associated with skin hypopigmentation, in particular vitiligo.

L'invention a également pour objet l'utilisation dans une composition cosmétique, ou pour la préparation d'une composition pharmaceutique, d'un extrait végétal selon l'invention ; l'extrait ou la composition étant destinés à favoriser la pigmentation des poils et/ou des cheveux.The invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, of a plant extract according to the invention; the extract or the composition being intended to promote the pigmentation of the hairs and / or the hair.

L'invention se rapporte encore à l'utilisation dans une composition cosmétique, ou pour la préparation d'une composition pharmaceutique, d'un extrait végétal selon l'invention ; l'extrait ou la composition étant destinés à préparer la peau à une exposition au soleil.The invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, of a plant extract according to the invention; the extract or the composition being intended to prepare the skin for exposure to the sun.

L'invention se rapporte encore à l'utilisation dans une composition cosmétique, ou pour la préparation d'une composition pharmaceutique, d'un extrait végétal selon l'invention ; l'extrait ou la composition étant destinés, par l'augmentation de la synthèse de mélanine, à protéger la peau des rayonnements du soleil.The invention also relates to the use in a cosmetic composition, or for the preparation of a pharmaceutical composition, a plant extract according to the invention; the extract or the composition being intended, by increasing melanin synthesis, to protect the skin from sunlight.

Selon une autre forme de l'invention, l'utilisation de l'extrait végétal ou de la composition le contenant est destinée à protéger la peau des stress environnementauxAccording to another form of the invention, the use of the plant extract or of the composition containing it is intended to protect the skin from environmental stress.

Selon un mode de réalisation avantageux de l'invention, l'extrait végétal est préalablement solubilisé dans un ou plusieurs solvants cosmétiquement ou pharmaceutiquement acceptables comme l'eau, le glycérol, le propylène glycol, le butylène glycol, les diglycols éthoxylés ou propoxylés, l'éthanol, le propanol ou l'isopropanol.According to an advantageous embodiment of the invention, the plant extract is first solubilized in one or more cosmetically or pharmaceutically acceptable solvents such as water, glycerol, propylene glycol, butylene glycol, ethoxylated or propoxylated diglycols, ethanol, propanol or isopropanol.

Selon encore un autre mode de réalisation avantageux de l'invention, l'extrait végétal est préalablement solubilisé dans un vecteur cosmétique ou pharmaceutique comme les liposomes ou adsorbé sur des polymères organiques poudreux, des supports minéraux comme les talcs et bentonites, et plus généralement solubilisé dans, ou fixé sur, tout vecteur cosmétiquement ou pharmaceutiquement acceptable.According to yet another advantageous embodiment of the invention, the plant extract is first solubilized in a cosmetic or pharmaceutical vector such as liposomes or adsorbed on organic powdery polymers, mineral supports such as talcs and bentonites, and more generally solubilized in, or attached to, any cosmetically or pharmaceutically acceptable carrier.

Pour donner un ordre de grandeur, dans les compositions cosmétiques ou dermatologiques de la présente invention, l'extrait végétal est utilisé en une quantité représentant de 0,0001 % à 20 % du poids total de la composition, et préférentiellement en une quantité représentant de 0,05 % à 5 % du poids total de la composition.To give an order of magnitude, in the cosmetic or dermatological compositions of the present invention, the plant extract is used in an amount representing from 0.0001% to 20% of the total weight of the composition, and preferably in a quantity representing from 0.05% to 5% of the total weight of the composition.

Ainsi, la teneur en composés de nature protéique et peptidique, dans les compositions de la présente invention, sera alors de 0,00003 % à 18% et préférentiellement de 0,015 % à 9 % du poids total de la composition, pour des extraits végétaux contenant entre 30 et 90 % de composés de nature protéique et peptidique. Ou encore, la teneur en composés de nature protéique et peptidique dans les compositions de la présente invention, sera de 0,0006 % àThus, the content of protein and peptide compounds in the compositions of the present invention will then be from 0.00003% to 18% and preferably from 0.015% to 9% of the total weight of the composition, for plant extracts containing between 30 and 90% of compounds of protein and peptide nature. Or, the content of protein and peptide compounds in the compositions of the present invention will be 0.0006% to

16 % et préférentiellement de 0,03 % à 8 % du poids total de la composition, pour des extraits végétaux contenant entre 60 et 80 % de composés de nature protéique et peptidique.16% and preferably from 0.03% to 8% of the total weight of the composition, for plant extracts containing between 60 and 80% of compounds of protein and peptide nature.

Outre l'intérêt majeur de la pigmentation de la peau dans la protection solaire, un composé pro-pigmentant selon l'invention offre des débouchés dans les produits auto-bronzants et les produits favorisant le bronzage. Pour cela, l'invention se rapporte à l'utilisation d'extrait végétal pour la fabrication de produits pour le bronzage et/ou le brunissage artificiels de la peau.In addition to the major advantage of the pigmentation of the skin in the sun protection, a pro-pigmenting compound according to the invention offers outlets in the self-tanning products and the products promoting tanning. For this, the invention relates to the use of plant extract for the manufacture of products for artificial tanning and / or browning of the skin.

L'invention se rapporte aussi à l'utilisation d'extrait végétal pour améliorer l'intensité et/ou l'homogénéité et/ou la persistance de la coloration produite sur la peau et/ou les cheveux.The invention also relates to the use of plant extract to improve the intensity and / or the homogeneity and / or the persistence of the coloration produced on the skin and / or the hair.

Préférentiellement, les compositions selon la présente invention se présenteront sous une forme adaptée à l'administration par voie topique cutanée, et couvrent toutes les formes cosmétiques ou dermatologiques. Ces compositions doivent donc contenir un milieu cosmétiquement et/ou dermatologiquement acceptable, c'est-à-dire compatible avec la peau, les poils ou les cheveux. Ces compositions pourront notamment être sous forme de crèmes, émulsions H/E, E/H ou émulsions multiples, solutions, suspensions, gels, laits, lotions, sticks ou encore poudres, adaptés à une application sur la peau, les lèvres et/ou les cheveux. Ces compositions comprennent les excipients nécessaires à leur formulation, tels que solvants, épaississants, diluants, tensioactifs, anti-oxydants, colorants, conservateurs, parfums.Preferably, the compositions according to the present invention will be in a form suitable for topical administration to the skin, and cover all cosmetic or dermatological forms. These compositions must therefore contain a cosmetically and / or dermatologically acceptable medium, that is to say compatible with the skin, hair or hair. These compositions may especially be in the form of creams, O / W emulsions, W / O emulsions or multiple emulsions, solutions, suspensions, gels, milks, lotions, sticks or even powders, suitable for application to the skin, the lips and / or the hair. These compositions comprise the excipients necessary for their formulation, such as solvents, thickeners, diluents, surfactants, antioxidants, dyes, preservatives, perfumes.

Bien entendu, l'homme de métier veillera à choisir les éventuels composés complémentaires, actifs ou non-actifs, et/ou leur quantité, de telle sorte que les propriétés avantageuses du mélange ne soient pas, ou sensiblement pas, altérées par l'adjonction envisagée.Of course, those skilled in the art will take care to choose any additional compounds, active or non-active, and / or their quantity, so that the advantageous properties of the mixture are not, or not substantially, impaired by the addition considered.

La composition utilisable selon l'invention peut en particulier consister en une composition pour soins capillaires, et notamment un shampooing, un après-shampooing, une lotion de mise en plis, une lotion traitante, une crème ou un gel coiffant, une lotion restructurante pour les cheveux, un masque, etc. La composition cosmétique selon l'invention peut être utilisée notamment dans les traitements mettant en oeuvre une application qui est suivie ou non suivie d'un rinçage, ou encore sous forme de shampooing.The composition that may be used according to the invention may in particular consist of a composition for hair care, and in particular a shampoo, a conditioner, a setting lotion, a treatment lotion, a cream or a styling gel, a restructuring lotion for hair, a mask, etc. The cosmetic composition according to the invention can be used in particular in treatments using an application that is followed or not followed by rinsing, or in the form of shampoo.

Elle peut également se présenter sous forme de teinture ou de mascara à appliquer au pinceau ou au peigne, en particulier sur les cils, les sourcils ou les cheveux.It can also be in the form of dye or mascara to be applied with a brush or a comb, in particular on eyelashes, eyebrows or hair.

II est bien entendu évident que les extraits végétaux selon l'invention, principalement constitués de composés de nature protéique et peptidique, pourront être utilisés en tant que seul agent pro-pigmentant ou bien en association avec au moins un autre agent actif, dans une composition cosmétique ou pour la préparation d'une composition dermatologique et/ou pharmaceutique.It is of course obvious that the plant extracts according to the invention, mainly consisting of protein and peptide compounds, may be used as the only pro-pigmenting agent or in combination with at least one other active agent, in a cosmetic composition or for the preparation of a dermatological and / or pharmaceutical composition.

Avantageusement, les compositions utilisables selon l'invention contiennent en outre au moins un autre agent favorisant la pigmentation de la peau, des cheveux et/ou des poils.Advantageously, the compositions that can be used according to the invention also contain at least one other agent that promotes the pigmentation of the skin, hair and / or hair.

De tels composés sont notamment des substrats de la tyrosinase, tels que la tyrosine ou la L- DOPA, des prostaglandines, ou des composés activateurs de la voie de l'AMPc tels que des dérivés de pro-opiomélanocortines, l'adénosine, ou la forkoline ou ses dérivés. On peut également citer des extraits de végétaux tels que le bigaradier (citrus aurantiurή) ou de chrysanthème (Chrysanthemum morifolium), décrits notamment dans les brevets FR 2845285 et EP1014934.Such compounds are in particular tyrosinase substrates, such as tyrosine or L-DOPA, prostaglandins, or activating compounds of the cAMP pathway such as pro-opiomelanocortin derivatives, adenosine, or forkoline or its derivatives. It may also be mentioned plant extracts such as bitter orange (citrus aurantiur) or chrysanthemum (Chrysanthemum morifolium), described in particular in patents FR 2845285 and EP1014934.

De tels composés se trouvent également dans la famille des colorants exogènes des couches superficielles de l'épidémie, tels que la dihydroxyacétone (DHA), l'érythrulose, les extraits de feuilles de henné, décrits notamment dans les brevets EP 0742002, FR2779958.Such compounds are also found in the family of exogenous dyes of the superficial layers of the epidemic, such as dihydroxyacetone (DHA), erythrulose, extracts of henna leaves, described in particular in patents EP 0742002 and FR2779958.

D'autres avantages et caractéristiques de l'invention apparaîtront mieux à la lecture des exemples donnés à titre illustratif et non limitatif.Other advantages and characteristics of the invention will appear better on reading the examples given by way of illustration and not limitation.

Exemple 1 : Préparation des extraits végétaux L'agent actif peut être obtenu à partir d'un extrait de grains de l'espèce Pisum sativum L. (pois), mais bien entendu l'extrait peut être préparé à partir de plantes d'au moins l'une quelconque des nombreuses variétés et espèces appartenant au genre Pisum. L'agent actif peut être obtenu à partir d'un extrait de grains de l'espèce Vhaseolus vulgaris (haricot). Bien entendu l'extrait peut être préparé à partir de plantes d'au moins l'une quelconque des nombreuses variétés et espèces appartenant au genre Phaseolus.Example 1 Preparation of Plant Extracts The active agent can be obtained from an extract of grains of the species Pisum sativum L. (pea), but of course the extract can be prepared from plants of minus any of the many varieties and species belonging to the genus Pisum. The active agent can be obtained from a grain extract of the species Vhaseolus vulgaris (bean). Of course the extract can be prepared from plants of at least one of many varieties and species belonging to the genus Phaseolus.

L'agent actif peut être obtenu à partir d'un extrait de fèves (ou grains) de l'espèce Theobroma cacao L. (cacao). Bien entendu l'extrait peut être préparé à partir de plantes d'au moins l'une quelconque des nombreuses variétés et espèces appartenant au genre Theobroma. L'agent actif peut être obtenu à partir d'un extrait de graines de l'espèce Amaranthus hypochondriacus (amarante). Bien entendu l'extrait peut être préparé à partir de plantes d'au moins l'une quelconque des nombreuses variétés et espèces appartenant au genre Amaranthus. L'agent actif peut être obtenu à partir d'un extrait de grains de l'espèce Oryza sativa L. (riz). Bien entendu l'extrait peut être préparé à partir de plantes d'au moins l'une quelconque des nombreuses variétés et espèces appartenant au genre Oryza.The active agent can be obtained from an extract of beans (or grains) of the species Theobroma cacao L. (cocoa). Of course the extract may be prepared from plants of at least one of many varieties and species belonging to the genus Theobroma. The active agent can be obtained from a seed extract of the species Amaranthus hypochondriacus (amaranth). Of course, the extract can be prepared from plants of at least one of many varieties and species belonging to the genus Amaranthus. The active agent can be obtained from an extract of grains of the species Oryza sativa L. (rice). Of course the extract can be prepared from plants of at least one of the many varieties and species belonging to the genus Oryza.

Dans une première étape, 1 kg de grains décortiqués sont délipidés par l'action d'un solvant organique : l'hexane. Les grains sont ensuite broyés dans un broyeur à couteau puis sont mis en suspension dans une solution aqueuse alcaline (dilution au 1/10). Ce mélange est maintenu sous agitation pendant un temps suffisamment long pour permettre la solubilisation des fractions solubles. La température d'extraction est variable (comprise entre 4 et 80°C) ; préférentiellement l'opération sera réalisée à froid. Après cette phase d'extraction le milieu est clarifié par centrifugation puis filtré sur filtre à plaque. Ce filtrat qui contient les fractions solubles du végétal est ensuite soumis à une précipitation des protéines en faisant varier la force ionique en milieu neutre ou acide, ce qui permet d'éliminer les composants glucidiques solubles, les lipides et les acides nucléiques. Le surnageant est éliminé et le précipité est ensuite lavé à l'aide d'un solvant tel que, par exemple, l'éthanol ou le méthanol puis le solvant est évaporé par séchage sous vide. A ce stade, on obtient environ 50 grammes de poudre de couleur jaune clair d'extrait protéique brut contenant : Protéines : 75 % - Glucides : 20 %In a first step, 1 kg of shelled grains are delipidated by the action of an organic solvent: hexane. The grains are then milled in a knife mill and then suspended in an aqueous alkaline solution (1/10 dilution). This mixture is stirred for a time long enough to allow the solubilization of the soluble fractions. The extraction temperature is variable (between 4 and 80 ° C); preferably the operation will be performed cold. After this extraction phase, the medium is clarified by centrifugation and then filtered through a plate filter. This filtrate which contains the soluble fractions of the plant is then subjected to precipitation of the proteins by varying the ionic strength in neutral or acidic medium, which allows to eliminate soluble carbohydrate components, lipids and nucleic acids. The supernatant is removed and the precipitate is then washed with a solvent such as, for example, ethanol or methanol and the solvent is evaporated by drying in vacuo. At this stage, about 50 grams of light yellow powder of crude protein extract are obtained containing: Protein: 75% - Carbohydrates: 20%

Lipides : 5 %Fat: 5%

Le précipité riche en protéines est remis en solution dans l'eau ou un autre solvant. L'extraction peut également être réalisée en milieu neutre ou acide. L'extrait protéique brut est alors soumis à une série d'hydrolyses ménagées et sélectives consistant en des hydrolyses chimiques et enzymatiques. A titre d'exemple on peut citer l'hydrolyse en présence d'exopeptidases (papaïne, ficine).The protein-rich precipitate is dissolved in water or another solvent. The extraction can also be carried out in neutral or acidic medium. The crude protein extract is then subjected to a series of gentle and selective hydrolyses consisting of chemical and enzymatic hydrolyses. By way of example, mention may be made of hydrolysis in the presence of exopeptidases (papain, ficin).

L'hydrolysat est ensuite purifié puis dialyse sur membrane pour éliminer les composés de haut poids moléculaire. On obtient alors un hydrolysat de couleur claire titrant de 15 à 30 g/1 d'extrait sec et contenant une quantité de composés de nature protéique et peptidiques représentant environ 70 % du poids total de la matière sèche. L'extrait hydrolyse selon l'invention est alors dilué de telle sorte que la concentration en protéines déterminée par la méthode de Lowry, soit comprise entre 0,5 et 2 g/1. Exemple 2 : Etude ex vivo de l'effet de l'extrait végétal selon l'exemple 1 sur la synthèse de mélanineThe hydrolyzate is then purified and membrane-dialyzed to remove the high molecular weight compounds. A light-colored hydrolyzate titrant of 15 to 30 g / l of dry extract and containing a quantity of protein and peptide compounds representing approximately 70% of the total weight of the dry matter is then obtained. The hydrolyzed extract according to the invention is then diluted so that the protein concentration determined by the Lowry method is between 0.5 and 2 g / l. Example 2 Ex Vivo Study of the Effect of the Plant Extract According to Example 1 on the Synthesis of Melanin

Le but de cette étude ex vivo est de mettre en évidence l'augmentation de la mélanisation apportée par l'extrait selon l'exemple 1. Protocole : Des biopsies de peau humaine de 6 mm de diamètre sont maintenues en culture ex vivo en présence d'un milieu spécifique (DMEM lg/L, HAMF 12, SVF et antibiotiques) sur des inserts déposés dans des plaques 6 puits. Les biopsies sont cultivées pendant 48 heures et reçoivent ou non 2 applications par jour d'extrait selon l'exemple 1 à une concentration de 1 %. Les biopsies sont ensuite fixées dans le formol 9 %, NaCl (150 mM) pendant 10 heures puis incluses dans la paraffine. Des coupes de peau de 3 μm d'épaisseur sont ensuite réalisées et la mélanine est colorée spécifiquement par la technique de Fontana-The purpose of this ex vivo study is to demonstrate the increase in melanization provided by the extract according to Example 1. Protocol: Human skin biopsies 6 mm in diameter are maintained in culture ex vivo in the presence of a specific medium (DMEM lg / L, HAMF 12, FCS and antibiotics) on inserts deposited in 6-well plates. The biopsies are cultured for 48 hours and receive or not 2 applications per day of extract according to Example 1 at a concentration of 1%. The biopsies are then fixed in 9% formalin, NaCl (150 mM) for 10 hours and then included in the paraffin. Skin sections 3 μm thick are then made and the melanin is stained specifically by the Fontana technique.

Masson.Masson.

Résultats : Les coupes de peau n'ayant pas reçu l'application d'extrait selon l'exemple 1 présentent une coloration de faible intensité. Au contraire, les coupes de peau ayant reçu les applications d'extrait selon l'exemple 1 présentent une coloration d'intensité nettement augmentée. De plus, la mélanine est située dans la couche basale, mais aussi transportée dans les couches supra-basales.Results: Skin sections that did not receive the application of extract according to Example 1 have a low intensity coloration. On the contrary, the skin sections having received the extract applications according to Example 1 exhibit a markedly increased color intensity. In addition, melanin is located in the basal layer, but also transported in the supra-basal layers.

Conclusions : 48 heures de traitement ont permis d'induire une forte augmentation de la synthèse de mélanine par les mélanocytes et de stimuler l'ensemble du processus de répartition de la mélanine dans l'épidémie.Conclusions: 48 hours of treatment led to a strong increase of melanin synthesis by melanocytes and to stimulate the whole process of distribution of melanin in the epidemic.

Exemple 3 : Préparation de compositionsExample 3 Preparation of compositions

Ces compositions ont été obtenues par simple mélange des différents composants. Les quantités indiquées sont données en pourcentage de poids.These compositions were obtained by simple mixing of the various components. The quantities indicated are given as a percentage of weight.

1-Emulsion huile-dans-eau1-oil-in-water emulsion

Phase huileuse :Oily phase:

B Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside) 5.00 %B Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside) 5.00%

B Huile de Jojoba 5.00 %B Jojoba Oil 5.00%

" Huile de Vaseline 5.00 %"Vaseline Oil 5.00%

" Isopropyl Palmitate 7.00 %"Isopropyl Palmitate 7.00%

Phase aqueuse :Aqueous phase :

B Glycérine 5.00 % Allantoïne 0.10 %B Glycerin 5.00% Allantoin 0.10%

Extrait selon l'exemple 1 1.00 %Extract according to example 1 1.00%

Sepigel 305 (Polyacrylamide and C13-14 Isoparaffin and Laureth-7) 0.30 %Sepigel 305 (Polyacrylamide and C13-14 Isoparaffin and Laureth-7) 0.30%

Conservateur 0.50 %Conservative 0.50%

Parfum 0.50 %Perfume 0.50%

Eau qsp 100 %Water qs 100%

2- Gel a Carbopol Ultrez 10 (sol. à 2% ) 25.00 % " Triéthanolamine 0.50 %2- Carbopol Ultrez Gel 10 (2% sol) 25.00% Triethanolamine 0.50%

• Extrait selon l'exemple 1 5.00 %• Extract according to example 1 5.00%

B Conservateur 0.20 %B Conservative 0.20%

B EDTA (séquestrant) 0.10 %B EDTA (sequestering) 0.10%

B Parfum 0.50 % B Eau qsp 100 %B Perfume 0.50% B Water qs 100%

3- Lotion3- Lotion

B Mono Propylène Glycol 1.00 %B Mono Propylene Glycol 1.00%

B Allantoïne 0.30 % B Glycérine 1.00 %B Allantoin 0.30% B Glycerin 1.00%

B Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00 %B Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00%

B Extrait selon l'exemple 1 0.5 %B Extract according to example 1 0.5%

B Conservateur 0.20 %B Conservative 0.20%

B Parfum 0.50 % B Eau qsp 100 %B Perfume 0.50% B Water qs 100%

4-Emulsion autobronzante huile-dans-eau Phase huileuse :4-Oil-in-water self-tanning emulsion Oily phase:

B Mélange mono/distéarate de glycérol 2.00 % B Alcool stéarylique 1.00 %B Glycerol mono / distearate mixture 2.00% B Stearyl alcohol 1.00%

B Acide stéarique d'huile de palme 1.50 % B PoIy diméthylsiloxane 2.00 %B Palm oil stearic acid 1.50% B PoIy dimethylsiloxane 2.00%

B Mélange poly diméthylsiloxane alpha-omega 3.00 % dihydroxyle/cyclopentadiméthylsiloxane (14,7/85,3) • Lauroyl sarconisate d'isopropyle 15.00 % Phase aqueuse :B Poly dimethylsiloxane mixture alpha-omega 3.00% dihydroxyl / cyclopentadimethylsiloxane (14.7 / 85.3) • Lauroyl isopropyl sarconisate 15.00% Aqueous phase:

B Dihydroxyacétone 5.00 % m Glycérine . 5.00 % B Phosphate d'alcool hexadécylique, sel de potassium 1.00 %B Dihydroxyacetone 5.00% m Glycerin. 5.00% B Hexadecyl alcohol phosphate, potassium salt 1.00%

B Acide polyacrylique 0.30 %B Polyacrylic acid 0.30%

B Triéthanolamine qsp pH : 7B Triethanolamine qsp pH: 7

B Acétate de dl-alpha-tocopheryle 0.50 %B dl-alpha-tocopheryl acetate 0.50%

B Extrait selon l'exemple 1 1.00 % B Eau déminéralisée qsp 100.00 %B Extract according to Example 1 1.00% B Demineralized water qs 100.00%

5-Emulsion autobronzante eau-dans-huile5-Self-tanning water-in-oil emulsion

Phase huileuse :Oily phase:

B Polydiméthyl 2.00 % B Phényl triméthylsiloxy trisiloxane 3.00 %B Polydimethyl 2.00% B Phenyl trimethylsiloxy trisiloxane 3.00%

B Lauroyl sarcosinate d'isopropyle 10.00 %B Lauroyl isopropyl sarcosinate 10.00%

B Isohexadecane 5.00 %B Isohexadecane 5.00%

B Cyclopenta dimethylsiloxane 3.00 %B Cyclopenta dimethylsiloxane 3.00%

Phase aqueuse : B Dihydroxyacétone 2.00 %Aqueous phase: B Dihydroxyacetone 2.00%

B Glycérine 5.00 %B Glycerin 5.00%

B Sulfate de magnésium 0.70 %B Magnesium sulphate 0.70%

B Extrait selon l'exemple 1 1.00 %B Extract according to example 1 1.00%

B Eau déminéralisée qsp 100.00 %B Demineralized water qs 100.00%

6- Lotion autobronzante6- Self-tanning lotion

B Dihydroxyacétone 5.00 %B Dihydroxyacetone 5.00%

B Extrait lyophilisé άΕclipta prostata 0.40 % m Ethanol à 96% 13.00 % B Ethoxydiglycol 7.00 %B Freeze-dried extract άΕclipta prostata 0.40% m 96% ethanol 13.00% B Ethoxydiglycol 7.00%

B Eumulgin® L (PPG- l-PEG-9-Lauryl Glycol Ether) 5.00 %B Eumulgin ® L (PPG-l-PEG-9 Lauryl Glycol-Ether) 5.00%

B Parabens 0.25 %B Parabens 0.25%

B Extrait selon l'exemple 1 1.00 % Eau déminéralisée qsp 100.00 %B Extract according to example 1 1.00% Demineralized water qs 100.00%

7- Emulsion huile-dans-eau autobronzante7- Self-tanning oil-in-water emulsion

B Eau 66.80 % B Ethoxydiglycol 5.00 %B Water 66.80% B Ethoxydiglycol 5.00%

B Xanthan gum 0.30 %B Xanthan gum 0.30%

B Cetyl hydroxyethylcellulose 0.30 %B Cetyl hydroxyethylcellulose 0.30%

B Cetyl alcohol 2.00 %B Cetyl alcohol 2.00%

B Stearyl alcohol 2.00 % m Octyl palmitate 2.00 %B Stearyl alcohol 2.00% m Octyl palmitate 2.00%

B Glucam P-20 distearate 2.00 %B Glucam P-20 distearate 2.00%

B Steareth-20 1.00 %B Steareth-20 1.00%

B Dimethicone 1.00 % m Polysorbate 60 1.00 % B Dimethicone Copolyol/IPDI Copolymer 1.00 %B Dimethicone 1.00% m Polysorbate 60 1.00% B Dimethicone Copolyol / IPDI Copolymer 1.00%

B Glycerylstearate and PEG-100 stéarate 0.25 % m Actiplex 335 Lipo OP 0.1 %B Glycerylstearate and PEG-100 Stearate 0.25% m Actiplex 335 Lipo OP 0.1%

" Tocopheryl acétate 0.1 % a Eau 10.975 % β Dihydroxyacetone 2.00 %"Tocopheryl acetate 0.1% a Water 10.975% β Dihydroxyacetone 2.00%

" Nipaguard MPA 0.60 % β Panthenol, 50% aqueux 0.40 %"Nipaguard MPA 0.60% β Panthenol, 50% aqueous 0.40%

" Sorbic acid 0.05 %"Sorbic acid 0.05%

B Sodium metabisulfite 0.025 % a Extrait selon l'exemple 1 1.00 % B Sodium metabisulfite 0.025% a Extract according to Example 1 1.00%

Claims

REVENDICATIONS 1. Utilisation d'un extrait végétal obtenu à partir de plantes choisies parmi les genres Amaranthus ou Oryza ou les espèces Pisum sativum L. (pois), Phaseolus vulgaris (haricot) ou Theobroma cacao L. (cacao), principalement constitué de composés de nature protéique et peptidique, seul ou en association avec au moins un autre agent actif, dans une composition cosmétique, l'extrait ou la composition le contenant étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épiderme ou du bulbe pileux et à améliorer la pigmentation naturelle de la peau.1. Use of a plant extract obtained from plants selected from the genera Amaranthus or Oryza or the species Pisum sativum L. (pea), Phaseolus vulgaris (bean) or Theobroma cacao L. (cocoa), consisting mainly of protein and peptide nature, alone or in combination with at least one other active agent, in a cosmetic composition, the extract or the composition containing it being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb and improve the natural pigmentation of the skin. 2. Utilisation d'un extrait végétal obtenu à partir de plantes choisies parmi les genres Amaranthus ou Oryza ou les espèces Pisum sativum L. (pois), Phaseolus vulgaris2. Use of a plant extract obtained from plants selected from the genera Amaranthus or Oryza or the species Pisum sativum L. (pea), Phaseolus vulgaris (haricot) ou Theobroma cacao L. (cacao), principalement constitué de composés de nature protéique et peptidique, seul ou en association avec au moins un autre agent actif, pour la préparation d'une composition dermatologique et/ou pharmaceutique, l'extrait ou la composition le contenant étant destinés à favoriser l'augmentation de la synthèse de mélanine dans les mélanocytes de l'épiderme ou du bulbe pileux et à atténuer les désordres pigmentaires associés à une hypopigmentation de la peau.(bean) or Theobroma cacao L. (cocoa), consisting mainly of protein and peptide compounds, alone or in combination with at least one other active agent, for the preparation of a dermatological and / or pharmaceutical composition, the extract or the composition containing it being intended to promote the increase of melanin synthesis in the melanocytes of the epidermis or hair bulb and to attenuate the pigmentary disorders associated with hypopigmentation of the skin. 3. Utilisation selon les revendications 1 ou 2, caractérisée en ce que les plantes appartenant au genre Amaranthus sont de l'espèce Amaranthus hypochondriacus (amarante).3. Use according to claims 1 or 2, characterized in that the plants belonging to the genus Amaranthus are of the species Amaranthus hypochondriacus (amaranth). 4. Utilisation selon les revendications 1 ou 2, caractérisée en ce que les plantes appartenant au genre Oryza sont de l'espèce Oryza sativa L. (riz).4. Use according to claims 1 or 2, characterized in that the plants belonging to the genus Oryza are of the species Oryza sativa L. (rice). 5. Utilisation selon l'une quelconque des revendications précédentes, caractérisée en ce que l'extrait végétal contient une quantité de composés de nature protéique et peptidique, représentant entre 30 % et 90 % du poids total de la matière sèche et plus particulièrement entre 60 % et 80 % du poids total de la matière sèche. 5. Use according to any one of the preceding claims, characterized in that the plant extract contains a quantity of compounds of protein and peptide nature, representing between 30% and 90% of the total weight of the dry matter and more particularly between 60 % and 80% of the total weight of the dry matter. 6. Utilisation selon l'une quelconque des revendications précédentes, caractérisée en ce que la composition se présente sous une forme adaptée à l'application par voie topique comprenant un milieu cosmétiquement ou dermatologiquement acceptable.6. Use according to any one of the preceding claims, characterized in that the composition is in a form suitable for topical application comprising a cosmetically or dermatologically acceptable medium. 7. Utilisation selon l'une quelconque des revendications précédentes, caractérisée en ce que l'extrait est utilisé en une quantité représentant de 0,0001 % à 20 % du poids total de la composition, et préférentiellement en une quantité représentant de 0,05 % à 5 % du poids total de la composition.7. Use according to any one of the preceding claims, characterized in that the extract is used in an amount representing from 0.0001% to 20% of the total weight of the composition, and preferably in an amount representing 0.05 % to 5% of the total weight of the composition. 8. Utilisation selon l'une quelconque des revendications précédentes, caractérisée en ce que la composition contient en outre au moins un colorant exogène des couches superficielles de l'épiderme et/ou au moins un agent actif pro-pigmentant différent dudit extrait selon les revendications 1 à 5, choisi parmi les substrats de la tyrosinase ou les prostaglandines ou les composés activateurs de la voie de l'AMPc ou les extraits végétaux pigmentants.8. Use according to any one of the preceding claims, characterized in that the composition further contains at least one exogenous dye of the surface layers of the epidermis and / or at least one pro-pigmenting active agent different from said extract according to the claims. 1 to 5, selected from tyrosinase substrates or prostaglandins or activating compounds of the cAMP pathway or plant extracts pigment. 9. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que l'extrait ou la composition le contenant sont destinés, par l'augmentation de la synthèse de mélanine, à préparer la peau à une exposition au soleil ou à protéger la peau des rayonnements du soleil.9. Use according to any one of the preceding claims characterized in that the extract or the composition containing it is intended, by increasing the synthesis of melanin, to prepare the skin for exposure to the sun or to protect the skin radiation from the sun. 10. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que l'extrait ou la composition le contenant sont destinés à protéger la peau des agressions extérieures, en particulier des rayons UV.10. Use according to any one of the preceding claims characterized in that the extract or composition containing it is intended to protect the skin from external aggressions, in particular UV rays. 11. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que l'extrait ou la composition le contenant sont destinés au bronzage et/ou au brunissage artificiels de la peau.11. Use according to any one of the preceding claims characterized in that the extract or the composition containing it are intended for artificial tanning and / or browning of the skin. 12. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que l'extrait ou la composition le contenant sont destinés à améliorer l'intensité et/ou l'homogénéité et/ou la persistance de la pigmentation de la peau et/ou des cheveux. 12. Use according to any one of the preceding claims characterized in that the extract or the composition containing it are intended to improve the intensity and / or the homogeneity and / or the persistence of the pigmentation of the skin and / or hair. 13. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que l'extrait ou la composition le contenant sont destinés à prévenir ou à traiter le blanchiment des poils et/ou des cheveux. 13. Use according to any one of the preceding claims characterized in that the extract or the composition containing it are intended to prevent or treat the whitening of the hair and / or hair.
PCT/FR2007/001333 2006-08-03 2007-08-02 Use of a plant extract as active agent for increasing melanin synthesis in melanocytes Ceased WO2008015341A2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
FR0607092 2006-08-03
FR0607099A FR2904542B1 (en) 2006-08-03 2006-08-03 USE OF EXTRACT OF COCOA BEANS AS AN ACTIVE AGENT TO INCREASE MELANIN SYNTHESIS IN MELANOCYTES
FR0607105 2006-08-03
FR0607103 2006-08-03
FR0607105A FR2904546A1 (en) 2006-08-03 2006-08-03 Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
FR0607099 2006-08-03
FR0607103A FR2904545B1 (en) 2006-08-03 2006-08-03 USE OF AMARANTE EXTRACT AS ACTIVE AGENT FOR INCREASING THE SYNTHESIS OF MELANIN IN MELANOCYTES
FR0607092A FR2904556B1 (en) 2006-08-03 2006-08-03 USE OF PEAS EXTRACT AS ACTIVE AGENT FOR INCREASING THE SYNTHESIS OF MELANIN IN MELANOCYTES
FR0607102 2006-08-03
FR0607102A FR2904544A1 (en) 2006-08-03 2006-08-03 Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation

Publications (2)

Publication Number Publication Date
WO2008015341A2 true WO2008015341A2 (en) 2008-02-07
WO2008015341A3 WO2008015341A3 (en) 2008-04-10

Family

ID=38963092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/001333 Ceased WO2008015341A2 (en) 2006-08-03 2007-08-02 Use of a plant extract as active agent for increasing melanin synthesis in melanocytes

Country Status (1)

Country Link
WO (1) WO2008015341A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010150922A3 (en) * 2009-06-25 2011-03-10 Shiseido Company, Ltd. Methods for screening for anti-graying agents on the basis of aff-4 expression
WO2011128530A1 (en) * 2010-04-15 2011-10-20 Isp Investments Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
FR2962038A1 (en) * 2010-07-01 2012-01-06 Isp Investments Inc USE OF PEPTIDE PEA EXTRACT AS ANTIOXIDANT ACTIVE AGENT IN A COSMETIC COMPOSITION
US8231916B2 (en) * 2006-07-18 2012-07-31 Laboratoires Expanscience Use of a rice protein hydrolysate as pigmenting active principle
EP2862598A1 (en) * 2013-10-16 2015-04-22 Legacy Healthcare Holding Ltd. Use of a composition for the pigmentation of hair and hairs
WO2017157998A1 (en) * 2016-03-16 2017-09-21 ISP Investments LLC. Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same
US10357531B2 (en) 2013-11-08 2019-07-23 Legacy Healthcare Ltd. Method for the management of cancer and cancer treatment-related comorbidities

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654935B1 (en) * 1989-11-28 1994-07-01 Lvmh Rech USE OF XANTHINES, WHICH MAY BE INCORPORATED IN LIPOSOMES, TO PROMOTE PIGMENTATION OF THE SKIN OR HAIR.
JPH0825891B2 (en) * 1993-06-25 1996-03-13 株式会社薬理学中央研究所 Lipase inhibitor derived from defatted rice germ
FR2746303B1 (en) * 1996-03-21 1998-06-12 Fabre Pierre Dermo Cosmetique AMARANTE SEED EXTRACT AND DERMO-COSMETIC COMPOSITION COMPRISING THE SAME
JPH09255526A (en) * 1996-03-27 1997-09-30 Shiseido Co Ltd Anti-aging cosmetics
US5698184A (en) * 1996-08-23 1997-12-16 Skin Biology, Inc. Compositions and methods for skin tanning and protection
DE19827624A1 (en) * 1998-06-20 1999-12-23 Beiersdorf Ag Use of catechols or plant extracts containing them in intensifying natural skin tanning or in stimulating melanogenesis
JP2002212039A (en) * 2001-01-17 2002-07-31 Shiseido Co Ltd Gray hair preventing agent
FR2825925B1 (en) * 2001-06-19 2005-01-28 Silab Sa PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS
FR2834718B1 (en) * 2002-01-15 2004-12-24 Cognis France Sa COSMETIC AND / OR PHARMACEUTICAL ACTIVE SUBSTANCES
WO2004080380A2 (en) * 2003-03-05 2004-09-23 L'oreal Use of catechuic polyphenols for preparing compositions for stimulating a skin's natural pigmentation
FR2877568B1 (en) * 2004-11-10 2008-03-21 Oreal COSMETIC COMPOSITION COMPRISING RICE PROTEIN HYDROLYSAT AND AGENT INCREASING GLYCOSAMINOGLYCAN SYNTHESIS

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231916B2 (en) * 2006-07-18 2012-07-31 Laboratoires Expanscience Use of a rice protein hydrolysate as pigmenting active principle
WO2010150922A3 (en) * 2009-06-25 2011-03-10 Shiseido Company, Ltd. Methods for screening for anti-graying agents on the basis of aff-4 expression
US9199101B2 (en) 2010-04-15 2015-12-01 Isp Investments Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
WO2011128530A1 (en) * 2010-04-15 2011-10-20 Isp Investments Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
US20130029917A1 (en) * 2010-04-15 2013-01-31 Isp Investment Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
FR2962038A1 (en) * 2010-07-01 2012-01-06 Isp Investments Inc USE OF PEPTIDE PEA EXTRACT AS ANTIOXIDANT ACTIVE AGENT IN A COSMETIC COMPOSITION
WO2012001246A3 (en) * 2010-07-01 2012-03-22 Isp Investments Inc. Use of a peptidic pea extract as an active antioxidant in a cosmetic composition
CN105813694A (en) * 2013-10-16 2016-07-27 传统医疗保健有限公司 Use of a composition for the pigmentation of hair and hairs
KR102344747B1 (en) * 2013-10-16 2021-12-30 레거시 헬스케어 (스위스) 에스에이 Use of a composition for the pigmentation of hair and hairs
KR20160063401A (en) * 2013-10-16 2016-06-03 레거시 헬스케어 리미티드 Use of a composition for the pigmentation of hair and hairs
EP2862598A1 (en) * 2013-10-16 2015-04-22 Legacy Healthcare Holding Ltd. Use of a composition for the pigmentation of hair and hairs
JP2016533371A (en) * 2013-10-16 2016-10-27 レガシー ヘルスケア リミテッド Use of compositions for pigmentation of hair
US20220117880A1 (en) * 2013-10-16 2022-04-21 Legacy Healthcare Ltd. Use Of A Composition For The Pigmentation Of Hair And Hairs
US11219592B2 (en) 2013-10-16 2022-01-11 Legacy Healthcare (Switzerland) Sa Use of a composition for the pigmentation of hair and hairs
WO2015055739A1 (en) * 2013-10-16 2015-04-23 Legacy Healthcare Ltd Use of a composition for the pigmentation of hair and hairs
US10357531B2 (en) 2013-11-08 2019-07-23 Legacy Healthcare Ltd. Method for the management of cancer and cancer treatment-related comorbidities
CN109152727A (en) * 2016-03-16 2019-01-04 Isp投资有限责任公司 Peptide and sugar hydrolysate, the cosmetic use containing its cosmetic composition and the cosmetic composition of cocoa bean
CN109152727B (en) * 2016-03-16 2021-08-20 Isp投资有限责任公司 Peptides and sugar hydrolyzates of cocoa beans, cosmetic compositions containing them, and cosmetic uses of the cosmetic compositions
US10932477B2 (en) 2016-03-16 2021-03-02 Isp Investments Llc Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same
FR3048881A1 (en) * 2016-03-16 2017-09-22 Isp Investments Inc PEPTIDE AND OSIDIC HYDROLYZATION OF COCOA BEANS, COSMETIC COMPOSITIONS COMPRISING THE SAME AND THEIR COSMETIC USES
WO2017157998A1 (en) * 2016-03-16 2017-09-21 ISP Investments LLC. Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same
US11503840B2 (en) 2016-03-16 2022-11-22 ISP Investments LLC. Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same

Also Published As

Publication number Publication date
WO2008015341A3 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
WO2008015343A2 (en) Use of a yeast extract as active agent for increasing melanin synthesis in melanocytes
WO2008015342A2 (en) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
EP2049074A1 (en) Use of a rice protein hydrolysate as pigmenting active principle
EP1776082B1 (en) Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition
EP2182964B1 (en) Use of a flax extract in a cosmetic or dermatological composition for activating cytochrome c
WO2008015341A2 (en) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2928547A1 (en) EXTRACT OF BRASSOCATTLE MARCELLA KOSS ORCHID AND USE THEREOF AS SKIN DEPIGMENTING AGENT
EP3618802A1 (en) Use of a nephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes
EP0993826B1 (en) Use of a Sanguisorba officinalis extract to stimulate the skin- and/or the hair-pigmentation
FR2915381A1 (en) Use of an active ingredient obtained from hydrolyzed soy, in a cosmetic composition or for preparing a pharmaceutical composition comprising the ingredient or composition to activate cytochrome and stimulate mitochondrion
FR2904552A1 (en) USE OF A YEAST EXTRACT AS AN ACTIVE AGENT TO INCREASE MELANIN SYNTHESIS IN MELANOCYTES
EP2421885B1 (en) Bleaching peptide hydrolysate proteasome activator and compositions containing same
EP2086564B1 (en) Peptide-containing pharmaceutical and/or cosmetic composition
EP2086565B1 (en) Cosmetic and/or pharmaceutical composition containing at least one peptide as the active ingredient and use of said peptide
FR2904556A1 (en) Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
WO2008015344A2 (en) Dermatological and/or cosmetic composition containing polypeptides or peptides of the protein slc24a5
FR2904546A1 (en) Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
EP2590622B1 (en) Use of populus balsamifera extract as depigmenting agent
FR2904543A1 (en) Use of a vegetable extract e.g. obtained from genus Linum made of proteic/peptidic compounds, to enhance the augmentation of melanin synthesis in melanocytes of the epidermis or hair bulb and improves the natural pigmentation of the skin
FR2904542A1 (en) Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
FR2904555A1 (en) Use of a vegetable extract e.g. obtained from genus Linum made of proteic/peptidic compounds, to enhance the augmentation of melanin synthesis in melanocytes of the epidermis or hair bulb and improves the natural pigmentation of the skin
FR2904544A1 (en) Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
FR2904545A1 (en) Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
FR2904541A1 (en) Use of a vegetable extract e.g. obtained from genus Linum made of proteic/peptidic compounds, to enhance the augmentation of melanin synthesis in melanocytes of the epidermis or hair bulb and improves the natural pigmentation of the skin
FR2904540A1 (en) Use of a vegetable extract e.g. obtained from genus Linum made of proteic/peptidic compounds, to enhance the augmentation of melanin synthesis in melanocytes of the epidermis or hair bulb and improves the natural pigmentation of the skin

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07823386

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07823386

Country of ref document: EP

Kind code of ref document: A2